Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Cyberonics, Inc.'s financial performance into perspective.

Recent Releases

Jan 3, 2012
Cyberonics Announces FDA Approval of Re-Designed AspireHC™ Generator for VNS Therapy

Dec 1, 2011
Cyberonics to Host Investor and Analyst Meeting at Corporate Headquarters in Houston

View all releases »